Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,080	982.02	739.02	563.95	449.54	373.65
Revenue Growth (YoY)	39.56%	32.88%	31.04%	25.45%	20.31%	30.31%
Cost of Revenue	379.2	349.01	289.8	227.05	156.33	122.91
Gross Profit	701.01	633.01	449.22	336.9	293.21	250.74
Selling, General & Admin	781.86	706.07	545.06	451.03	463.78	398.52
Research & Development	366.71	364.19	347.75	367.19	373.81	263.22
Other Operating Expenses	-	-	-	83.4	-	-
Total Operating Expenses	1,149	1,070	892.81	901.62	837.59	661.74
Operating Income	-447.56	-437.25	-443.59	-564.73	-544.38	-411
Interest Income	36.13	34.1	53.69	35.37	6.07	3.93
Interest Expense	-4.45	-3.9	-2.58	-2.58	-2.58	-2.58
Other Non-Operating Income (Expense)	-18.5	-10.49	-42.61	53.17	-112.56	25.18
Total Non-Operating Income (Expense)	13.18	19.71	8.51	85.96	-109.07	26.53
Pretax Income	-434.37	-417.54	-435.09	-478.76	-653.45	-384.47
Provision for Income Taxes	-1.18	-1.26	1.28	0.99	1.14	0.3
Net Income	-433.19	-416.28	-436.37	-479.45	-654.59	-405.67
Minority Interest in Earnings	-	-	-	-	-	20.9
Net Income to Common	-433.19	-416.28	-436.37	-479.45	-654.59	-405.67
Shares Outstanding (Basic)	127	125	123	112	102	101
Shares Outstanding (Diluted)	127	125	123	112	102	101
Shares Change (YoY)	3.19%	2.14%	9.61%	9.60%	0.85%	3.91%
EPS (Basic)	-3.39	-3.32	-3.56	-4.28	-6.41	-4.00
EPS (Diluted)	-3.39	-3.32	-3.56	-4.28	-6.41	-4.00
Shares Outstanding	131.51	130.64	123.99	121.63	102.62	101.77
Free Cash Flow	-237.12	-233.07	-274.94	-345.46	-386.92	-284.05
Free Cash Flow Per Share	-1.86	-1.86	-2.24	-3.08	-3.79	-2.80
Gross Margin	64.90%	64.46%	60.79%	59.74%	65.23%	67.11%
Operating Margin	-41.43%	-44.53%	-60.02%	-100.14%	-121.10%	-110.00%
Profit Margin	-40.10%	-42.39%	-59.05%	-85.02%	-145.61%	-102.97%
FCF Margin	-21.95%	-23.73%	-37.20%	-61.26%	-86.07%	-76.02%
EBITDA	-408.62	-397.51	-401.21	-521.84	-508.42	-388.73
EBITDA Margin	-37.83%	-40.48%	-54.29%	-92.53%	-113.10%	-104.04%
EBIT	-447.56	-437.25	-443.59	-564.73	-544.38	-411
EBIT Margin	-41.43%	-44.53%	-60.02%	-100.14%	-121.10%	-110.00%
Effective Tax Rate	0.27%	0.30%	-0.30%	-0.21%	-0.17%	-0.08%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q